← Leaderboards
Deepak Voora
Ralph H Johnson Va Medical Center
$4,400,964
Attributed
$4,851,552
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $987.6K · FY2013–25$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,851,552 · 3
VA$0 · 1
By mechanism
R01$3,886,343 · 1
U01$965,209 · 2
I01$0 · 1
Top collaborators
- Dawn Marie Bravata3 shared
- Lori Ann Orlando1 shared
- Maren Theresa Scheuner1 shared
- Jason L Vassy1 shared
Most similar at Ralph H Johnson Va Medical Center
Same institution · by research overlap
- Dawn Marie Bravata$1,047,692
- Chanita A Hughes-Halbert$21,790,824
Others in their field
Top investigators on “Laboratories”
- David Heimbrook · Leidos Biomedical Research, Inc.$943,075,715
- Lawrence Corey · Fred Hutchinson Cancer Center$747,603,944
- Jeffrey P Krischer · University Of South Florida$627,303,958
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$553,634,937
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$463,311,620
Research focus
LaboratoriesInnovationHigh RiskProtocols DocumentationPreventDoseCardiovascular Risk FactorPreventionSafetyParticipantBaseTechnologyResponseMissionGene ExpressionDiagnosticAspirinDiagnostic TestsGenesBypassCommunity SettingCoronary ArteryBlood PlateletsBlood
Grant awards (12)
Reducing Veterans' Risk of Atherosclerotic Cardiovascular Disease Through Pharmacogenomics Informed Statin Prescribing$0
I01 · FY2025 · VA · contact PI
Reducing Veterans' Risk of Atherosclerotic Cardiovascular Disease Through Pharmacogenomics Informed Statin Prescribing$0
I01 · FY2025 · VA · contact PI
The VA Genomics Learning Health System: Implementing genomic medicine across diverse veteran communities$600,784
U01 · FY2024 · HG
Reducing Veterans' Risk of Atherosclerotic Cardiovascular Disease Through Pharmacogenomics Informed Statin Prescribing$0
I01 · FY2024 · VA · contact PI
Building and Deploying a Genomic-Medicine Risk Assessment Model for Diverse Primary Care Populations.$364,425
U01 · FY2022 · HG · contact PI
Development Of Prognostic Platelet RNA Biomarkers To Tailor Antiplatelet Therapy$690,729
R01 · FY2017 · HL · contact PI
Development Of Prognostic Platelet RNA Biomarkers To Tailor Antiplatelet Therapy$766,082
R01 · FY2016 · HL · contact PI
Development Of Prognostic Platelet RNA Biomarkers To Tailor Antiplatelet Therapy$728,609
R01 · FY2015 · HL · contact PI
Development Of Prognostic Platelet RNA Biomarkers To Tailor Antiplatelet Therapy$158,979
R01 · FY2015 · HL · contact PI
Development Of Prognostic Platelet RNA Biomarkers To Tailor Antiplatelet Therapy$99,997
R01 · FY2015 · HL · contact PI
Development Of Prognostic Platelet RNA Biomarkers To Tailor Antiplatelet Therapy$739,666
R01 · FY2014 · HL · contact PI
Development Of Prognostic Platelet RNA Biomarkers To Tailor Antiplatelet Therapy$702,281
R01 · FY2013 · HL · contact PI